PAVmed Inc (NASDAQ:PAVM) — Market Cap & Net Worth
Market Cap & Net Worth: PAVmed Inc (PAVM)
PAVmed Inc (NASDAQ:PAVM) has a market capitalization of $7.86 Million ($7.86 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27427 globally and #5431 in its home market, demonstrating a -6.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PAVmed Inc's stock price $8.53 by its total outstanding shares 921284 (921.28K). Analyse how efficiently does PAVmed Inc generate cash to see how efficiently the company converts income to cash.
PAVmed Inc Market Cap History: 2016 to 2026
PAVmed Inc's market capitalization history from 2016 to 2026. Data shows change from $95.35 Million to $7.86 Million (-27.42% CAGR).
Index Memberships
PAVmed Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #801 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2595 of 3165 |
Weight: PAVmed Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
PAVmed Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PAVmed Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.19x
PAVmed Inc's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
PAVmed Inc's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $34.00 Million | $500.00K | -$50.35 Million | 67.99x | N/A |
| 2022 | $6.63 Million | $377.00K | -$88.98 Million | 17.59x | N/A |
| 2023 | $3.80 Million | $2.45 Million | -$64.17 Million | 1.55x | N/A |
| 2024 | $578.11K | $3.00 Million | $39.79 Million | 0.19x | 0.01x |
Competitor Companies of PAVM by Market Capitalization
Companies near PAVmed Inc in the global market cap rankings as of May 4, 2026.
Key companies related to PAVmed Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
PAVmed Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, PAVmed Inc's market cap moved from $95.35 Million to $ 7.86 Million, with a yearly change of -27.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.86 Million | +3763.22% |
| 2025 | $203.42K | -64.81% |
| 2024 | $578.11K | -84.77% |
| 2023 | $3.80 Million | -42.78% |
| 2022 | $6.63 Million | -80.49% |
| 2021 | $34.00 Million | +16.04% |
| 2020 | $29.30 Million | +76.67% |
| 2019 | $16.58 Million | +24.74% |
| 2018 | $13.29 Million | -57.90% |
| 2017 | $31.58 Million | -66.88% |
| 2016 | $95.35 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of PAVmed Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.86 Million USD |
| MoneyControl | $7.86 Million USD |
| MarketWatch | $7.86 Million USD |
| marketcap.company | $7.86 Million USD |
| Reuters | $7.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more